Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03447314
Title Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

head and neck squamous cell carcinoma

Advanced Solid Tumor

Therapies

GSK1795091 + GSK3174998

GSK3174998

Age Groups: senior | adult
Covered Countries USA | ESP | CAN

Facility Status City State Zip Country Details
GSK Investigational Site Boston Massachusetts 02215 United States Details
GSK Investigational Site Saint Louis Missouri 63110 United States Details
GSK Investigational Site Dallas Texas 75230 United States Details
GSK Investigational Site Houston Texas 77030 United States Details
GSK Investigational Site Tacoma Washington 98405 United States Details
GSK Investigational Site Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site Amsterdam 1066 CX Netherlands Details
GSK Investigational Site Barcelona 08035 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field